Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial

Lee S. Nguyen, Pierre Squara, Julien Amour, Daniel Carbognani, Kamel Bouabdallah, Stéphane Thierry, Caroline Apert-Verneuil, Aurélie Moyne, Bernard Cholley

Open source

DOI
10.1186/s13054-018-2124-8
Published
2018-08-17
Container
Critical Care
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13054-018-2124-8,
  title = {Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial},
  author = {Lee S. Nguyen and Pierre Squara and Julien Amour and Daniel Carbognani and Kamel Bouabdallah and Stéphane Thierry and Caroline Apert-Verneuil and Aurélie Moyne and Bernard Cholley},
  year = {2018},
  journal = {Critical Care},
  doi = {10.1186/s13054-018-2124-8},
  url = {https://doi.org/10.1186/s13054-018-2124-8}
}

RIS

TY  - JOUR
TI  - Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial
AU  - Lee S. Nguyen
AU  - Pierre Squara
AU  - Julien Amour
AU  - Daniel Carbognani
AU  - Kamel Bouabdallah
AU  - Stéphane Thierry
AU  - Caroline Apert-Verneuil
AU  - Aurélie Moyne
AU  - Bernard Cholley
PY  - 2018
JO  - Critical Care
DO  - 10.1186/s13054-018-2124-8
UR  - https://doi.org/10.1186/s13054-018-2124-8
ER  - 

APA

Nguyen, L. S., Squara, P., Amour, J., Carbognani, D., Bouabdallah, K., Thierry, S., Apert-Verneuil, C., Moyne, A., & Cholley, B. (2018). Intravenous ivabradine versus placebo in patients with low cardiac output syndrome treated by dobutamine after elective coronary artery bypass surgery: a phase 2 exploratory randomized controlled trial. Critical Care. https://doi.org/10.1186/s13054-018-2124-8

Source records